Senescence-messaging secretome: SMS-ing cellular stress
The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Abstract
Oncogene-induced cellular senescence constitutes a strong anti-proliferative response, which can be set in motion following either oncogene activation or loss of tumour suppressor signalling. It serves to limit the expansion of early neoplastic cells and as such is a potent cancer-protective response to oncogenic events. Recently emerging evidence points to a crucial role in oncogene-induced cellular senescence for the 'senescence-messaging secretome' or SMS, setting the stage for cross-talk between senescent cells and their environment. How are such signals integrated into a coordinated response and what are the implications of this unexpected finding?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the SASP reinforces and spreads senescence in autocrine and paracrine fashions (Acosta et al., 2013; Coppe ´ et al., 2010; Kuilman and Peeper, 2009) and activates immune responses that eliminate senescent cells (Krizhanovsky et al., 2008a; Mun ˜ oz-Espı ´n and Serrano, 2014).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“Senescent cells secrete a plethora of factors, including pro-inflammatory cytokines and chemokines, growth modulators, angiogenic factors, and matrix metalloproteinases (MMPs), collectively termed the senescent associated secretory phenotype (SASP) or senescence messaging secretome (SMS) (Figure 1; Table 2) (Coppe ´ et al., 2010; Kuilman and Peeper, 2009).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“OIS or senescence induced by loss of a tumor suppressor was verified in vivo in human and murine preneoplastic lesions (Collado et al., 2005; Gorgoulis and Halazonetis, 2010; Kuilman and Peeper, 2009) and primary or treated neoplasias (Haugstetter et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“In most studies, senescence is assessed in ex vivo cultures or fresh samples by SAb -gal staining or indirect markers in formalin-fixed tissues”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“This SASP or senescence messaging secretome (SMS) (Kuilman and Peeper 2009) reflects the non-cell-autonomous functionality of senescent cells and may underpin their in vivo role in the pathophysiology of aging and age-related disorders.”
From Cellular senescence and its effector programs (2014) · cites this paper as Kuilman and Peeper 2009
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“OIS corresponds to a premature form of cellular senescenc”
BackgroundCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“For instance, in a mouse model of liver carcinoma driven by inducible shRNA-mediated depletion of p53 and HRAS V12 expression, Scott Lowe's laboratory showed that reactivation of p53 in the tumour results in a robust senescence respons”
BackgroundSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“OIS and replicative senescence share a number of characteristics, including an increase in senescence-associated β-galactosidase (SA-β-GAL) activity and the condensation of individual chromosomes into distinct heterochromatic bodies, called senescence-associated heterochromatic foci (SAHF”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Self-citation
Research works printed but not linked: 1
- Gagnon, A. M., Chabot, J., Pardasani, D. & Sorisky, A. Extracellular matrix induced by TGFβ impairs insulin signal transduction in 3T3-L1 preadipose cells. J. Cell Physiol. 175, 370–378 (1998). · doi:10.1002/(sici)1097-4652(199806)175:3<370::aid-jcp15>3.0.co;2-9
Cited by
Items 601–700 of 910
Hornsby, P. J. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.07.011 · Cited by 20
“senescence resulting from telomere shortening and oncogene-induced senescence) [63,64].”
BackgroundCellular senescence in adult pulmonary hypertension: current state and future challenges
Lemay, S.-E. S., Kuwabara, Y., Bonnet, S., Potus, F., Provencher, S., Adnot, S., & Boucherat, O. (2025) · European Respiratory Review · doi:10.1183/16000617.0030-2025 · Cited by 16
“…a complex mixture of pro-inflammatory cytokines, chemokines, growth factors and ECM modifying factors, collectively referred to as the senescence-associated secretory phenotype (SASP) or senescence-messaging secretome, which represents the dark side of the senescence response (figure 2) [38, 39].”
MicroRNAs influence and longevity
Eshkoor, S. A., Ghodsian, N., & Akhtari‐Zavare, M. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00316-7 · Cited by 17
“These changes occur due to alterations probably happening in gene expressions [145], protein secretions [146], and inducibility of apoptosis, which may increase in senescent fibroblasts [147] and decrease in endothelial cells [148].”
BackgroundInduction of senescence upon loss of the Ash2l core subunit of H3K4 methyltransferase complexes
Bochyńska, A., Stenzel, A. T., Sayadi-Boroujeni, R., Kuo, C., Barsoum, M., Liang, W., Bussmann, P., Costa, I. G., Lüscher‐Firzlaff, J., & Lüscher, B. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac591 · Cited by 15
“One prominent consequence is the activation of SASP, which has been argued to occur in all senescent cells (22,42,43).”
BackgroundBarsoum, M., Stenzel, A. T., Bochyńska, A., Kuo, C., Tsompanidis, A., Sayadi-Boroujeni, R., Bussmann, P., Lüscher‐Firzlaff, J., Costa, I. G., & Lüscher, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-25881-0 · Cited by 15
Naushad, S., Gaucher, J., Mezdari, Z., Détrait, M., Belaïdi, E., Zhang, Y., Vial, G., Bouyon, S., Czibik, G., Pini, M., et al. (2024) · Acta Physiologica · doi:10.1111/apha.14231 · Cited by 15
“25 In the present study, we hypothesized that CIH induces WAT senescence and remodeling, which contributes to the induction of cardiac alterations.”
The role of mitochondria in cytokine and chemokine signalling during ageing
Kalykaki, M., Rubio‐Tomás, T., & Tavernarakis, N. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.111993 · Cited by 17
Head and neck cancer: from research to therapy and cure
Varelas, X., & Kukuruzinska, M. A. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12613 · Cited by 15
Cell Senescence in Myxoid/Round Cell Liposarcoma
Gustafsson, C. K., Ståhlberg, A., Engtröm, K., Danielsson, A., Turesson, I., & Åman, P. (2014) · Sarcoma · doi:10.1155/2014/208786 · Cited by 15
Upregulation of SOX4 antagonizes cellular senescence in esophageal squamous cell carcinoma
Han, R., Huang, S., Bao, Y., Liu, X. Z., Peng, X., Chen, Z., Wang, Q., Wang, J., Zhang, Q., Wang, T., et al. (2016) · Oncology Letters · doi:10.3892/ol.2016.4799 · Cited by 14
“This gene expression signature had the characteristics of SASP (5,20,21).”
InfluentialExpression profile‑driven discovery of AURKA as a treatment target for liposarcoma
Yen, C., Chen, S., Hung, G., Wu, P., Chua, W., Lin, Y., Yen, C., Chen, Y., Wang, J., Yang, M., et al. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4861 · Cited by 19
“7G), cytokines associated with the senescence-associated secretory phenotype (SASP) (29), in LPS853 cells.”
BackgroundPeeper, D. S. (2011) · Nature · doi:10.1038/479186a · Cited by 14
Self-citationSchreyer, L., Mittermeier, C., Franz, M. J., Meier, M. A., Martin, D. E., Maier, K. C., Huebner, K., Schneider‐Stock, R., Singer, S., Hölzer, K., et al. (2021) · Cancers · doi:10.3390/cancers13215373 · Cited by 16
Rajagopalan, S., Lee, E. C., DuPrie, M. L., & Long, E. O. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302384 · Cited by 19
“5B), a cytokine that is indispensable for establishing and maintaining the senescent state (22).”
BackgroundRags connect mTOR and autophagy
Narita, M., & Inoki, K. (2012) · Small GTPases · doi:10.4161/sgtp.19422 · Cited by 15
Martin, N., Raguz, S., Dharmalingam, G., & Gil, J. (2013) · Cell Cycle · doi:10.4161/cc.25331 · Cited by 14
“This secretome includes extracellular proteases, matrix components (such as MMPs), growth factors, proinflammatory cytokines (IL6, IL1α, IL1β), and chemokines (IL8, GROα, MCP1).(2) Cellular senescence is relevant in multiple physiological and pathological contexts.”
BackgroundSTAT3 Relays a Differential Response to Melanoma-Associated NRAS Mutations
Kim, J., Novak, D., Sachpekidis, C., Utikal, J. S., & Larribère, L. (2020) · Cancers · doi:10.3390/cancers12010119 · Cited by 17
“In addition, several kinases including AXL were described to be involved in the OIS [37].”
BackgroundRegulation of cellular senescence by innate immunity
Hou, J., Zheng, Y., & Gao, C. (2023) · Biophysics Reports · doi:10.52601/bpr.2023.230032 · Cited by 18
“…cells typically produce numerous molecules, collectively called the senescent-associated secretory phenotype (SASP), including angiogenic factors, matrix metalloproteinases (MMPs), growth modulators, and various proinflammatory chemokines and cytokines (Coppe et al. 2010; Kuilman and Peeper 2009).”
BackgroundCellular Senescence is a Common Characteristic Shared by Preneoplasic and Osteo-Arthritic Tissue
Brondello, J., Philipot, D., Djouad, F., Jørgensen, C., & Noël, D. (2010) · The Open Rheumatology Journal · doi:10.2174/1874312901004010010 · Cited by 15
“Such signals would be integrated into a coordinated response that can cause other cell components to prematurely senesce thereby establishing a pro-aging loop [20].”
BackgroundInfluentialZoncu, R., & Sabatini, D. M. (2011) · Science · doi:10.1126/science.1207552 · Cited by 13
Evasion of oncogene-induced senescence by gammaherpesviruses
Leidal, A. M., Pringle, E. S., & McCormick, C. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.09.009 · Cited by 13
Molecular Mechanisms of Pituitary Adenoma Senescence
Chesnokova, V., Zonis, S., Ben-Shlomo, A., Wawrowsky, K., & Melmed, S. K. (2010) · Frontiers of hormone research · doi:10.1159/000318489 · Cited by 16
Ratushnyy, A. Y., Rudimova, Y. V., & Buravkova, L. B. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919030088 · Cited by 13
Acosta, J. C., Snijders, A. P., & Gil, J. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_11 · Cited by 13
Griffith, B. D., Lazarus, J., McGue, J. J., Krishnan, S., D'Angelica, M. I., Shia, J., Dobrosotskaya, I. Y., Shi, J., Edwards, J., Rao, A. U. K., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1289402 · Cited by 13
Peropadre, A., Freire, P. F., & Hazen, M. J. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.09.020 · Cited by 13
Cellular senescence implication in mustard keratopathy
Soleimani, M., Baharnoori, S. M., Cheraqpour, K., Momenaei, B., Mirshahi, R., Chow, C., Shahjahan, S., Nguyen, T., Ashraf, M. J., Huang, X., et al. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109565 · Cited by 13
Wang, Y., Yu, S., Wang, X., Han, B., Zhao, F., Zhu, G., Hong, Y., & Xia, S. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2011.11 · Cited by 14
Senescence-Derived Extracellular Molecules as Modulators of Oral Cancer Development: A Mini-Review
Parkinson, E. K., James, E. L., & Prime, S. S. (2015) · Gerontology · doi:10.1159/000440954 · Cited by 16
β-elemene promotes the senescence of glioma cells through regulating YAP-CDK6 signaling.
Yang, D., Xu, X., Wang, X., Feng, W., Shen, X., Zhang, J., Liu, H., Xie, C., Wu, Q., Miao, X., et al. (2021) · PubMed · Cited by 18
Pertussis: an update on primary prevention and outbreak control.
Scott, P. T., Clark, J. B., & Miser, W. F. (1997) · PubMed · Cited by 12
Natural Products in Aging: Cellular Mechanisms and Emerging Therapeutics for Age‐Related Disorders
Dixit, V., Chaubey, K. K., Dayal, D., Chole, P. B., Manjunath, B. T., Bachheti, R. K., Gupta, P. C., Bachheti, A., & Worku, L. A. (2025) · Journal of Aging Research · doi:10.1155/jare/6868732 · Cited by 12
“Tese factors are essential in the maintenance and induction of senescence, chemo-attraction of immune cells, microenvironment alteration, and tumorigenesis [58].”
Zhao, Y., Sun, S., Lyu, Y., Gao, M., Lin, H., & Yang, C. (2023) · Chemical Communications · doi:10.1039/d2cc05550c · Cited by 11
Mapping the core senescence phenotype of primary human colon fibroblasts
Hattangady, N. G., Carter, K. T., Maroni-Rana, B., Wang, T., Ayers, J., Yu, M., & Grady, W. M. (2024) · Aging · doi:10.18632/aging.205577 · Cited by 14
Genetic and Epigenetic Interactions Involved in Senescence of Stem Cells
Iordache, F., Ionescu, A., & Alexandru, D. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179708 · Cited by 14
“Also, the high metabolic demands of senescent cells may arise from a metabolically highly active cell that has undergone extensive changes in protein expression and production, finally developing the SASP [31].”
BackgroundANGPTL4-the Link Binding Lipid Metabolism and Inflammation
Zhang, Y., Liang, J., Li, Z., Zuo, Y., & Dai, L. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673320024240829070906 · Cited by 12
Pèrié, L., Houël, C., Zambon, A., Guéré, C., Vié, K., Leroy‐Dudal, J., Vendrely, C., Agniel, R., Carreiras, F., & Picot, C. R. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114251 · Cited by 12
Palbociclib-Induced Cellular Senescence Is Modulated by the mTOR Complex 1 and Autophagy
Cayo, Á., Venturini, W., Rebolledo-Mira, D., Moore‐Carrasco, R., Herrada, A. A., Nova‐Lamperti, E., Valenzuela, C. A., & Brown, N. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119284 · Cited by 14
“While some of these factors can maintain, or even promote, senescence in a paracrine manner [21], other SASP factors with documented proinflammatory action [22] can promote a pro-tumorigenic microenvironment that can lead to tumor recurrence or acceleration of tumor progression [23–25].”
BackgroundJinushi, M. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9501-9 · Cited by 11
“Senescence is not simply an arrest of cellular proliferation but also comprises the active processes of synthesizing various secretory forms of proteins, thereby affecting diverse sets of biological and immunological properties of the tissue microenvironment [44].”
BackgroundDetecting Markers of Therapy-Induced Senescence in Cancer Cells
Fan, D. N.-Y., & Schmitt, C. A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_4 · Cited by 14
“This is of particular importance, since the largely NF-κB-driven pro-inflammatory and matrix-remodeling components of the SASP may affect adjacent (pre-)tumor cells, profoundly alter the tumor microenvironment and attract host immune cells (1-4, 12, 19, 21, 22).”
BackgroundCellular senescence: Silent operator and therapeutic target in cancer
Ramu, D., Teoh, W. S., Hirpara, J. L., & Pervaiz, S. (2021) · IUBMB Life · doi:10.1002/iub.2460 · Cited by 13
“Manipulating SASP involves the factors that senescent cells secrete, which stabilize cell cycle and suppress oncogenesis by inducing an immune response.(114) Therefore, hypothetically, SASP factors could be developed into prototypal drugs.”
BackgroundPhosphoproteome Dynamics in Onset and Maintenance of Oncogene-induced Senescence
de Graaf, E. L., Kaplon, J., Zhou, H., Heck, A. J. R., Peeper, D. S., & Altelaar, M. A. F. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.035436 · Cited by 13
Self-citationNgassie, M. L. K., Thompson, M. A., Roos, B. B., Ayyalasomayajula, S., Lagnado, A. B., Passos, J. F., Pabelick, C. M., & Prakash, Y. S. (2025) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00348.2024 · Cited by 14
Jia, W., Yuan, J., Li, S., & Cheng, B. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189018 · Cited by 9
Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticity
Blander, H. D., Tonon, L., Fauvet, F., Pommier, R. M., Lamblot, C., Benhassoun, R., Angileri, F., Gibert, B., Rodriguez, R., Ouzounova, M., et al. (2024) · Science Advances · doi:10.1126/sciadv.adi1736 · Cited by 14
“Notably, OIS or senescence induced by loss of a tumor suppressor was observed in vivo in human and murine preneo-plastic lesions ( 51–53 ).”
Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence
Scanlan, R.-L., Pease, L., O’Keefe, H., Guimera, A. M., Rasmussen, L. J., Wordsworth, J., & Shanley, D. P. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1448543 · Cited by 11
“The SASP is a key characteristic of senescent cells involved in the spreading of secondary senescence (Acosta et al., 2013; Coppé et al., 2010; Kuilman and Peeper, 2009) and signalling to the immune system for senescent cell removal (Krizhanovsky et al., 2008; Muñoz-Espín and Serrano, 2014).”
BackgroundBanerjee, P., Olmsted‐Davis, E. A., Deswal, A. M., Nguyen, M. T. H., Koutroumpakis, E., Palaskas, N., Lin, S. H., Kotla, S., Reyes‐Gibby, C. C., Yeung, S. J., et al. (2022) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2022.13 · Cited by 11
Non‐pituitary growth hormone enables colon cell senescence evasion
Chesnokova, V., Zonis, S., Apaydın, T., Barrett, R. J., & Melmed, S. K. (2024) · Aging Cell · doi:10.1111/acel.14193 · Cited by 10
“SASP at-tracts immune effectors, leading to senescent cell depletion (Kang et al., 2011; Lee & Schmitt, 2019 ; Xue et al., 2007), and secondary senescence induction in neighboring cells (Acosta et al., 2013; Kuilman & Peeper, 2009 ).”
Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiers
David, G. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21116 · Cited by 10
Cotarelo, C., Schad, A., Schmidt, M., Hönig, A., Sleeman, J. P., & Thaler, S. (2023) · Cancers · doi:10.3390/cancers15061860 · Cited by 10
Non-pituitary GH regulation of the tissue microenvironment
Chesnokova, V., & Melmed, S. K. (2023) · Endocrine Related Cancer · doi:10.1530/erc-23-0028 · Cited by 15
Lindgren, T., Stigbrand, T. I., Råberg, A., Riklund, K., Johansson, L. F., & Eriksson, D. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2015.959668 · Cited by 10
“…profi le and start expressing senescenceassociated markers (SA- β -Gal) as well as molecules referred to as the SASP that includes cytokines, chemokines and matrix remodelling factors (Braig and Schmitt 2006, Acosta et al. 2008, Coppe et al. 2008, Kuilman et al. 2008, Kuilman and Peeper 2009).”
BackgroundEffects of CREG1 on Age-Associated Metabolic Phenotypes and Renal Senescence in Mice
Hashimoto, M., Goto, A., Endo, Y., Sugimoto, M., Ueda, J., & Yamashita, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031276 · Cited by 10
“This idea is supported by the finding that the mRNA levels of SASP-related cytokines such as Il-1beta, Il-6, Pai-1, and Ccl-2 were significantly decreased in the aged kidneys of Tg mice compared with those of WT mice.”
BackgroundInfluentialRuple, B. A., Mattingly, M. L., Godwin, J. S., McIntosh, M. C., Kontos, N. J., Agyin-Birikorang, A., Michel, J. M., Plotkin, D. L., Chen, S., Ziegenfuss, T. N., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202302103rrr · Cited by 9
“Based on comprehensive reviews, 44,45 versus Y participants.”
BackgroundPatel, S. J., Dao, S., Darie, C. C., & Clarkson, B. D. (2016) · PubMed Central · Cited by 10
Johnson, A. A., Naaldijk, Y., Hohaus, C., Meisel, H. J., Krystel, I., & Stolzing, A. (2016) · Aging · doi:10.18632/aging.101035 · Cited by 9
“DNA damage can cause cell apoptosis and senescence [24], which in turn can alter the secretome [25] and potentially hazard surrounding tissue.”
BackgroundCell Senescence and Mesenchymal Stromal Cells
Ratushnyy, A. Y., & Buravkova, L. B. (2020) · Human Physiology · doi:10.1134/s0362119720010132 · Cited by 9
de Castro, A., Minty, F., Hattinger, E., Wolf, R., & Parkinson, E. K. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-8 · Cited by 10
Gaur, M., Wang, L., Amaro-Ortiz, A., Dobke, M. K., Jordan, I. K., & Lunyak, V. V. (2017) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000396 · Cited by 12
“It is highly probable that SMS signals vary with time and include not only an autocrine feedback loop but also an ability of senescence cells to “listen” to the environment and respond to it by adjusting or spatially restricting SMS secretory output (schematically shown in Figure 7 and discussed in details [33].”
BackgroundBorodkina, A. V., Shatrova, A. N., Nikolsky, N. N., & Burova, E. (2016) · Cell and Tissue Biology · doi:10.1134/s1990519x16050023 · Cited by 9
“On the other hand, p38 plays a main role in fibroblast premature senescence initiated by overexpression of oncogenes, teloAbbreviations: ROS—reactive oxygen species, hMESCs—human edomerium-derived mesenchymal stem cells, MAPKAPK-2 (or MK-2)—MAP kinase-activated protein kinase 2, Rb–retinoblastoma protein, SASP—senesce…”
BackgroundKalisperati, P., Spanou, E., Pateras, I. S., Evangelou, K., Thymara, I., Korkolopoulou, P. A., Kotsinas, A., Vlachoyiannopoulos, P. G., Tzioufas, A. G., Kanellopoulos, C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073888 · Cited by 10
“Senescent cells are generally in an irreversible cell cycle arrest condition, non-proliferative but viable and metabolically active as they secrete various factors modulating the extracellular environment and neighboring cells, termed SASPs (senescence associated secretory phenotypes) [22–25].”
BackgroundLemay, S.-E. S., Mougin, M., Sauvaget, M., Kabbout, R. E., Valasarajan, C., Yamamoto, K., Martineau, S., Pelletier, A., Bilodeau, C., Grobs, Y., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101964 · Cited by 11
“28,29 Because many anti-cancer agents, including AURKB inhibition, not only induce apoptosis but can also elicit a senescent phenotype (known as therapy-induced senescence) that results in persistent cytosta-sis, 30 we thus investigated whether remaining AURKB-inhibited PAH-PASMCs display cellular…”
Chen, Y., Zhou, T., Zhou, R., Sun, W. C., Li, Y., Zhou, Q., Xu, D., Zhao, Y., Hu, P., Liang, J., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03363-1 · Cited by 12
“Besides, senescent cells can also influence their tumor microenvironment by producing a senescence-associated secretory phenotype (SASP) [54, 55].”
Induction and Detection of Oncogene-Induced Cellular Senescence in Drosophila
Nakamura, M., & Igaki, T. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_20 · Cited by 7
Zhu, S., Xing, C., Zhang, G., Peng, H., & Wang, Z. (2021) · American Journal of Translational Research · Cited by 11
A Micro-RNA Connection in BRafV600E -Mediated Premature Senescence of Human Melanocytes
Ren, G., Feng, J., Datar, I. J., Yeung, A. H., Saladi, S. V., Feng, Y., de la Serna, I. L., & Yeung, K. C. (2012) · International Journal of Cell Biology · doi:10.1155/2012/913242 · Cited by 11
“BRa f V600E-mediated senescence also requires additional effector pathways involving several immune and growth mediators such as IL6, IL8, and IGFBP7 [6].”
BackgroundSex Differences in Progression of Diabetic Cardiomyopathy in OVE26 Type 1 Diabetic Mice
Tang, X., Jiang, S., Zhang, J., Zhou, S., & Zheng, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6961348 · Cited by 8
Franceschi, C., Capri, M., Garagnani, P., Ostan, R., Santoro, A., Monti, D., & Salvioli, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_45-1 · Cited by 11
Engineering Antibodies Targeting p16 MHC-Peptide Complexes
Rettko, N. J., Campisi, J., & Wells, J. A. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00808 · Cited by 8
Fowler, E. W., van Venrooy, E. J., Witt, R. L., & Jia, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-19253-x · Cited by 11
Aging and the Host Response to Implanted Biomaterials
Rao, A. N., Avula, M., & Grainger, D. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800196-7.00011-6 · Cited by 8
Stellate Cells, Portal Myofibroblasts, and Epithelial-to-Mesenchymal Transition
Koyama, Y., Wang, P., Brenner, D. A., & Kisseleva, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00006-3 · Cited by 9
Transforming Growth Factor β1 (TGF-β1) in the Sera of Postmenopausal Osteoporotic Females
Faraji, A., Abtahi, S., Ghaderi, A. A., & Dehaghani, A. S. (2016) · Intern J Endocrinol Metab · doi:10.5812/ijem.36511 · Cited by 10
“As these cells age, they start secreting various factors, including TGF-β1 (34).”
BackgroundMerolle, M., Mongiardi, M. P., Piras, M., Levi, A., & Falchetti, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041490 · Cited by 8
“Although not dividing, senescent cells are metabolically active and secrete proinflammatory cytokines, chemokines, growth factors, and extracellular matrix-remodeling proteins, collectively named senescence-associated secretory phenotype (SASP) [15].”
BackgroundZhang, T., Zhao, B., Li, J., Zhang, C., Li, H., Wu, J., ZHANG, S., & Hui, G. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3062 · Cited by 8
“The pathway of p16/Rb or IL-6/C/EBP β mediates the oncogene-induced senescence (18,19).”
Dolan, M., Shi, Y., Mastri, M., Long, M. D., McKenery, A., Hill, J. W., Vaghi, C., Benzekry, S., Barbi, J. J., & Ebos, J. M. L. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0139 · Cited by 11
Sénescence et cancer: Double jeu
Goy, E., & Abbadie, C. (2018) · médecine/sciences · doi:10.1051/medsci/20183403010 · Cited by 10
Cartilage Regeneration and Tissue Engineering
Sancho‐Tello, M., Milián, L., Mata, M., de Llano, J. J. M., & Cardá, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816390-0.00018-2 · Cited by 8
Mazzoni, M., Mauro, G., Minoli, L., Cleris, L., Anania, M. C., Marco, T. D., Minna, E., Pagliardini, S., Rizzetti, M. G., Manenti, G., et al. (2021) · Biology · doi:10.3390/biology10100985 · Cited by 8
“Oncogene-induced senescence (OIS) is triggered by oncogene expression in primary cells; it is characterized by growth arrest and considered a mechanism impeding transformation and tumor progression of oncogene-expressing cells and, more in general, inhibiting cancer development [17].”
BackgroundKovach, A. R., Oristian, K. M., Kirsch, D. G., Bentley, R. C., Cheng, C., Chen, X. '., Chen, P., Chi, J., & Linardic, C. M. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13304 · Cited by 8
Ageing, Metabolic Dysfunction, and the Therapeutic Role of Antioxidants
Santos, A. L., & Sinha, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-26576-1_15 · Cited by 8
Endogenous anticancer mechanisms EACMs
Lenz, G. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s315 · Cited by 8
Targeted Senolytic Strategies Based on the Senescent Surfaceome
Ekpenyong‐Akiba, A. E., Poblocka, M., & Macip, S. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_6 · Cited by 8
Breathe it in – Spotlight on senescence and regeneration in the lung
Majewska, J., & Krizhanovsky, V. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111550 · Cited by 7
C/EBPβ: lost beyond translation
Peeper, D. S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.288 · Cited by 7
“Correspondingly, whereas active C/EBPb lacking the 30UTR stimulated the senescence-associated secretome as expected (Kuilman and Peeper, 2009), the full-length messenger failed to do so.”
BackgroundSelf-citationTo clear, or not to clear (senescent cells)? That is the question
Lujambio, A. (2016) · Inside the Cell · doi:10.1002/icl3.1046 · Cited by 11
Senescence versus apoptosis in chemotherapy
Ansieau, S., & Collin, G. (2015) · Oncotarget · doi:10.18632/oncotarget.3114 · Cited by 8
Overview of molecular signatures of senescence and associated resources: pros and cons
Ntintas, O. A., Vagena, S., Pantelis, P., Theocharous, G., Petty, R., Evangelou, K., & Gorgoulis, V. G. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70134 · Cited by 6
Changes in senescence markers after a weight loss intervention in older adults with obesity
Lynch, D. H., Petersen, C. L., Stewart, D. A., Justice, J. N., Batchek, D. J., Sumner, S., McRitchie, S., & Batsis, J. A. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105685 · Cited by 6
Cellular Senescence in the Regenerative Niche Hampers Skeletal Muscle Repair
Qiu, M., Li, Y., Wang, Q., Jian, X., Huang, J.-W., Gui, W., Hu, J., & Liao, H. (2025) · Aging and Disease · doi:10.14336/ad.2024.1501 · Cited by 10
“SASP is regulated by enhancer remodeling and activation of transcription factors such as NF-κB, C/EBPβ, GATA4, mammalian target of rapamycin (mTOR) and p38MAPK signaling pathways [31 – 33].”
Rademacher, D. J., Exline, J. E., & Foecking, E. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061400 · Cited by 9
“SASP mediators from senescent cells are thought to underlie inflammaging [226].”
Zhang, J., Cai, W., Liu, D., Zheng, N., Wang, Y., Qiu, F., He, Z., Gan, H., Huang, Y., Zhou, Y., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102331 · Cited by 11
“2,3 Aging also disrupts immune and metabolic functions in diabetes, further aggravating the disease condition.”
A Need for Refined Senescence Biomarkers and Measures of Senolytics in the Brain
Orr, M. E. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231462 · Cited by 6
Physioxia rewires mitochondrial complex composition to protect stem cell viability
Raabe, J., Wittig, I., Laurette, P., Σταθοπούλου, Κ., Brand, T., Schulze, T., Klampe, B., Orthey, E., Cabrera‐Orefice, A., Meisterknecht, J., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103352 · Cited by 6
Senolytic treatment attenuates immune cell infiltration without improving IAV outcomes in aged mice
Luna, A. J., Chou, K., Wragg, K. M., Worley, M. J., Paruchuri, N., Zhou, X., Blin, M. G., Moore, B. B., Salmon, M., Goldstein, D. R., et al. (2025) · Aging Cell · doi:10.1111/acel.14437 · Cited by 6
“The senescent cells also adopt a phenotype known as senescence-associated secretory phenotype (SASP) in which they secrete inflammatory cytokines, chemokines, and extracellular matrix-degrading enzymes (Kuilman & Peeper, 2009).”
Autophagy Detection During Oncogene-Induced Senescence Using Fluorescence Microscopy
Narita, M., & Narita, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_8 · Cited by 6
Exosomes and Exosomal microRNAs in Age-associated Stroke
Wang, X., Fu, C. H., Zhu, X., Liu, J., Gong, X., Pan, Q., & Ma, X. (2021) · Current Vascular Pharmacology · doi:10.2174/1570161119666210208202621 · Cited by 7
PICS-ure This: Prosenescence Therapy?
Peeper, D. S. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.028 · Cited by 8
“Senescence is often associated with the secretion of dozens of factors that mediate communication between senescent cells and their microenvironment (Kuilman and Peeper, 2009).”
BackgroundSelf-citationEpigenetic alteration to activate Bmp2-Smad signaling in Raf-induced senescence
Fujimoto, M., Mano, Y., Anai, M., Yamamoto, S., Fukuyo, M., Aburatani, H., & Kaneda, A. (2016) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v7.i1.188 · Cited by 6
Tumor-Independent Host Secretomes Induced By Angiogenesis and Immune-Checkpoint Inhibitors
Mastri, M., Lee, C. R., Tracz, A., Kerbel, R. S., Dolan, M., Shi, Y., & Ebos, J. M. L. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1066 · Cited by 5
Metadata
- Authors
- Kuilman, T., & Peeper, D. S.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Corresponding author
- Peeper, Daniel S.
- Venue
- Nature Reviews Cancer
- Published
- 2009-01-09
- Volume
- 9
- Issue
- 2
- Pages
- 81-94
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2005248738
- Cited by
- 909
- References
- 146
- Citations by year
- 2026: 25 · 2025: 46 · 2024: 46 · 2023: 48 · 2022: 54 · 2021: 73 · 2020: 62 · 2019: 43 · 2018: 63 · 2017: 56 · 2016: 60 · 2015: 53 · 2014: 68 · 2013: 55 · 2012: 47
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- secreted factors, senescence-associated secretory phenotype, cancer protection
- MeSH terms
- Animals, Cell Communication, Humans, Neoplasms, Signal Transduction, Cellular Senescence, Tumor Suppressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.